BDBM50099729 5-{2-[3-Carboxy-1-(carboxymethyl-carbamoyl)-propylcarbamoyl]-pyrrolidin-1-yl}-4-{4-carboxy-2-[(9,10-dioxo-9,10-dihydro-phenanthrene-2-carbonyl)-amino]-butyrylamino}-5-oxo-pentanoic acid::CHEMBL50046

SMILES OC(=O)CCC(NC(=O)C1CCCN1C(=O)C(CCC(O)=O)NC(=O)C(CCC(O)=O)NC(=O)c1ccc-2c(c1)C(=O)C(=O)c1ccccc-21)C(=O)NCC(O)=O

InChI Key InChIKey=GGCFNCAHFRRDDC-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50099729   

TargetReceptor-type tyrosine-protein phosphatase C(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099729(5-{2-[3-Carboxy-1-(carboxymethyl-carbamoyl)-propyl...)
Affinity DataIC50: 1.10E+3nMAssay Description:In vitro inhibitory activity against the cytosolic portion of CD45 protein-tyrosine phosphatase using pNPP as the substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed